Randox at AACC 2018 - Booth #3624

Location : McCormick Place, Chicago, Illinois
  Date : July 31st - August 2nd 2018

Cardiac Risk

Reagents

Randox are at the forefront of developing high quality diagnostic solutions for the cardiology field. We are revolutionising the early detection of cardiovascular disease through our innovations that make a real difference to both the clinician and the patient.

 

icons4

Apolipoprotein A-I

Studies have shown that there is an inverse relationship between Apolipoprotein A-I and coronary artery disease (CAD), whereas Apolipoprotein B has a direct relationship with CAD. Patients with CAD generally display reduced levels of Apolipoprotein A-I and increased levels of Apolipoprotein B.
Key Features:

  • Liquid ready-to-use reagents – for convenience and ease-of-use
  • Wide measuring range – of 6.50-233 mg/dl for measurement of clinically important results
  • Limited interference – from Bilirubin, Haemoglobin, Intralipid® and Triglycerides, producing more accurate results
  • Applications available for an extensive range of biochemistry analysers – which detail instrument-specific settings for the convenient use of Randox Apolipoprotein A-I assays on a variety of systems

 

icons4

Apolipoprotein B

Apolipoprotein B is often tested alongside Apolipoprotein A-I to determine the Apolipoprotein B/Apolipoprotein A-I ratio which can be used as an alternative to the Total Cholesterol /HDL Cholesterol ratio when determining cardiovascular risk.
Key features:

  • Liquid ready-to-use reagents – for convenience and ease-of-use
  • Extensive measuring range – of 11.2-184mg/dl for measurement of clinically important results
  • Limited interference – from Bilirubin, Haemoglobin, Intralipid® and Triglycerides, producing more accurate results
  • Applications available for an extensive range of biochemistry analysers– which detail instrument-specific settings for the convenient use of Randox Apolipoprotein B assays on a variety

 

icons3

Homocysteine

Raised levels of homocysteine can be associated with various disease states including cardiovascular disease, diabetes, dementia, osteoporosis and complications during pregnancy, making homocysteine an essential addition to a laboratory’s testing panel.

  • 2-part liquid ready-to-use kit with calibrators included
  • Minimal interference – ensuring accurate and precise results are produced every time
  • Excellent measuring range – 1.74-47.9µmol/l, enabling the Randox assay to detect abnormal levels related to all homocysteine associated disease states

 

icons2

Lipoprotein(a)

Elevated levels of Lipoprotein(a) (Lp(a)) are considered to be both a causal risk factor and independent genetic marker of atherosclerotic disorders. The major challenge with this test is the size variation of apo(a) within Lp(a). Dependent upon the size of apo(a) in the assay calibrator, many assays under or overestimate apo(a) size in the patient sample. The antibody used in the Randox method detects the complete Lp(a) molecule providing the most accurate and consistent results.

  • Liquid ready-to-use reagents
  • Superior methodology – displaying minimal Apo(a) size related bias
  • Five point calibrator available – giving a true reflection of the isoforms present in the population